This small molecule compound demonstrates exceptional ability to block nicotinamide N-methyltransferase enzyme activity, preventing NAD+ depletion while activating sirtuin pathways associated with healthy aging and metabolic optimization
The standard schedule keeps each injection at 3.2 mg: daily in weeks 14, five times per week in weeks 58, and two or three times weekly in weeks 912
Description Why 5-Amino-1MQ Is Redefining Lipid Metabolism Research Selective NNMT inhibitor -35% fat mass in 11 days without appetite reduction (preclinical model) Enzymatic Target NNMT Inhibitor Selective inhibition of nicotinamide N-methyltransferase (IC50 = 1.2 M)
known cases of chronic disease under treatment such as tuberculosis, diabetes, hypertension, hypo or hyperthyroidism, pernicious anaemia, Crohns disease and current use of anticonvulsant drugs
and dairy products such as milk, cheese, and yogurt
Achievement of optimal rates of lipolysis, therefore, likely requires the expression of both acyl hydrolases